Hemodialysis.com

Hemodialysis.com Author : Macaulay Onuigbo MD MSc FWACP FASN MBA

De novo HBV infection in a Mayo Clinic hemodialysis population: Economic impact of reduced HBV testing and a call for changes in current US CDC guidelines on HBV testing protocols.

Onuigbo, M. A. C. and Onuigbo, N. T. C. (2012)
Hemodialysis International, 16: S32–S38. doi: 10.1111/j.1542-4758.2012.00748.x

Hemodialysis.com Author Interview: Ning Wang, MD, PhD

Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis

Su, Y., Norris, J. L., Zang, C., Peng, Z. and Wang, N. (2012),. Hemodialysis International. doi: 10.1111/j.1542-4758.2012.00761.x

Dynavax: HEPLISAV, a Phase 3 Data on investigational adult Hep B vaccine, update in CKD and Hemodialysis Patients

BERKELEY, CA, Mar 27, 2012 (MARKETWIRE via COMTEX) -- Dynavax Technologies Corporation today announced final data from a pivotal Phase 3 trial in patients with chronic kidney disease (CKD) demonstrating early seroprotection and the durability of the immune response to HEPLISAV compared to Engerix-B(R). In October 2011, Dynavax reported that the superiority endpoint had been met in this trial. The trial included 516 patients 18-75 years of age with CKD (stage 3b or higher) in the U.S., Canada and Germany who received 3 doses of HEPLISAV at 0, 1 and 6 months or 4 double doses of Engerix-B at 0, 1, 2 and 6 months (8 doses total).

MACAULAY ONUIGBO MD MSc FWACP FASN FBC

Economic Impact of Reduced HBV Testing among Hemodialysis Patients in the New Environment of Bundling: Results of a Study of De Novo HBV Infection Rates in a Mayo Clinic Hemodialysis Population – A Call for Changes in Current US CDC Guidelines on HBV Testing Protocols

Abstract: [SA-PO3028]

Macaulay A. Onuigbo, MD, FASN, Nnonyelum T. Onuigbo, PhD. College of Medicine, Mayo Clinic, Rochester, MN; Nephrology/Hypertension/Transplant, Mayo Clinic Health System, Eau Claire, WI; Information Technology, NT Systems
Eau Claire, WI.

Author Interview: Dr. Juan Carlos Q. Velez

Therapeutic Response to Vasoconstrictors in Hepatorenal Syndrome Parallels Increase in Mean Arterial Pressure: A Pooled Analysis of Clinical Trials

Juan Carlos Q. Velez, Paul J. Nietert
American Journal of Kidney Diseases - 29 September 2011 (10.1053/j.ajkd.2011.07.017)

Author Interview: Prof. David Johnson

Effect of Dialysis Modality on Survival of Hepatitis C-Infected ESRF Patients

Bhadran Bose, Stephen P. McDonald, Carmel M. Hawley, Fiona G. Brown, Sunil V. Badve, Kathryn J. Wiggins, Kym M. Bannister, Neil Boudville, Philip Clayton, and David W. Johnson
CJASN September 8, 2011 CJN.02200311; published ahead of print September 8, 2011, doi:10.2215/CJN.02200311

Author Interview: Cheng-Chia Lee, MD

Comparable ten-year outcome in hemodialysis patients with hepatitis C virus and hepatitis B virus coinfection and single hepatitis B virus infection.
Lee CC, Li IJ, Chen YC, Cheng JW, Wu HH, Weng CH, Fang JT, Tian YC.
Department of Nephrology, Lin-Kou Chang Gung Memorial Hospital, Taipei, and Department of Medicine, Chang Gung University, Taiwan, ROC.
Blood Purif. 2011;32(2):89-95.

Author Interview: Dr. Craig Gordon

Long-Term Viral Negativity After Interferon for Chronic Hepatitis C Virus Infection in Hemodialysis.
Gordon CE, Uhlig K, Schmid CH, Levey AS, Wong JB.
Department of Medicine, Boston University Medical Center, Boston, Massachusetts;
Clin J Am Soc Nephrol. 2011 Jul 22.

Author Interview: Dr Ashik Hayat 

Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.

Nephrol Dial Transplant. 2011 Jul 18;
Authors: Mitwalli AH, Hayat A, Alwakeel J, Hammad D

Chronic viral hepatitis and chronic kidney disease.

Postgrad Med J. 2010 Aug;86(1018):486-92.

Chacko EC, et al
Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore 169608, Singapore.

Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C.

Clin Infect Dis. 2010 Jul 20.

Liu CH, et al

A Randomized Clinical Trial of Immunization With Combined Hepatitis A and B Versus Hepatitis B Alone for Hepatitis B Seroprotection in Hemodialysis Patients.
Am J Kidney Dis. 2010 Jul 12.
Tung J,
St. Joseph's Healthcare, Ontario, Canada.

Epidemiology, Surveillance, and Prevention of Hepatitis C Virus Infections in Hemodialysis Patients.

Am J Kidney Dis. 2010 Jun 4.
Patel PR, et al

Review article: Hepatitis B and dialysis.

Nephrology (Carlton). 2010 Mar;15(2):137-45.
Edey M, et al